Pfizer Doubles Price of Paxlovid, Raising Concerns About Access to Lifesaving Covid-19 Medication

Pfizer doubles the price of Paxlovid, raising concerns about access to lifesaving Covid-19 medication. Learn about the reasons for the increase, impact on access to medication, and Pfizer’s measures to mitigate the impact. Compare with Covid-19 vaccines and explore public reactions and Pfizer’s justification.

Slow and Inefficient Distribution of COVID-19 Vaccines in Nursing Homes

The slow and inefficient distribution of COVID-19 vaccines in nursing homes is hindering the protection of vulnerable residents. Challenges include vaccine hesitancy, administrative complications, limited access in rural areas, and lack of staff mandates. Alternative vaccines are being considered to address hesitancy, and an opportunity arises to offer a vaccine for respiratory syncytial virus (RSV). Stigma and misinformation further hinder vaccination efforts. Expediting distribution is crucial to safeguard nursing home residents. Find out more about this pressing issue in our article.